Hodgkin Lymphoma: What Should Newly Diagnosed Patients Know?

Hodgkin lymphoma is a cancer of the lymphatic system, which includes lymph nodes, the spleen and immune cells that help the body fight infection. In Hodgkin lymphoma, certain white blood cells grow abnormally, and form enlarged lymph nodes or masses.

Nodular sclerosis Hodgkin lymphoma is the most common subtype. It often starts in lymph nodes in the chest or neck and is frequently diagnosed in younger adults. Under the microscope, bands of scar-like tissue divide the lymph node into sections, which is how it gets its name.

The disease is considered highly treatable and often curable, even when diagnosed at later stages. Treatment decisions depend on the stage, symptoms, overall health and personal preferences. Conversations with an oncologist help tailor the approach.

“A diagnosis of Hodgkin lymphoma is not a death sentence. Thanks to numerous advances in medicine through clinical trials over time, Hodgkin lymphoma is a highly curable disease,” said Florida Cancer Specialists hematologist and medical oncologist, Dr. Napoleon Santos.

How is Hodgkin lymphoma diagnosed and staged?

Diagnosis usually begins with a biopsy of an enlarged lymph node. Imaging tests such as PET or CT scans help show where the disease has spread. Blood tests may evaluate organ function and overall health.

Doctors then assign a stage:

• Stage 1 means one lymph node region or one area is involved.
• Stage 2 involves two or more nearby regions on the same side of the diaphragm.
• Stage 3 affects lymph nodes on both sides of the diaphragm.
• Advanced or metastatic disease may involve organs such as the liver, lungs or bone marrow.

Staging guides how intensive treatment should be and helps estimate prognosis.

What are frontline treatment options for stage 1 and stage 2 Hodgkin lymphoma?

Early-stage disease is often treated with curative intent using combination chemotherapy, sometimes followed by radiation therapy.

Frontline therapy typically includes multi-drug chemotherapy given in cycles over several months. Some patients receive radiation to areas where lymphoma was present to lower the chance of recurrence. Treatment intensity may vary depending on tumor size, symptoms and PET scan results during therapy.

Second-line treatment, if the lymphoma returns or does not respond, may involve different chemotherapy combinations or targeted therapies. Third-line and beyond options can include stem cell transplant or newer immune-based treatments.

For many patients with stage 1 or stage 2 disease, outcomes are strong and long-term remission is common.

How is stage 3 Hodgkin lymphoma treated?

Stage 3 disease requires more systemic therapy because lymphoma is present on both sides of the diaphragm.

Frontline treatment usually consists of several months of combination chemotherapy. Radiation may still be used for bulky areas. Interim scans help doctors see how well the treatment is working and adjust if needed.

If the disease does not respond or returns, second-line chemotherapy followed by autologous stem cell transplant may be recommended. Third-line and later therapies often include targeted drugs or immunotherapies that help the immune system recognize lymphoma cells.

Even at this stage, many patients achieve long-term control.

What treatments are available for metastatic or advanced Hodgkin lymphoma?

Advanced or metastatic Hodgkin lymphoma is still commonly treated with curative intent.

Frontline therapy relies on full courses of combination chemotherapy. Treatment may be more intensive to address disease outside the lymph nodes.

Second-line approaches may include salvage chemotherapy and stem cell transplant. Third-line and beyond options include targeted agents and immunotherapies designed to block specific proteins or boost immune response.

Clinical trials may also be an option and can provide access to newer treatments. Discussing goals of care and quality of life is especially important when considering later-line therapies.

What side effects should patients expect from treatment?

Chemotherapy and radiation can cause both short- and long-term side effects. Common short-term effects include fatigue, nausea, hair loss, infections, low blood counts and appetite changes. Most improve after treatment ends.

Long-term risks may include heart or lung issues, thyroid changes, fertility concerns or a small risk of second cancers. Your care team may recommend fertility preservation or heart and lung monitoring before starting therapy. Reporting symptoms early can help manage side effects and maintain quality of life.

Conclusion: What conversations should you have with your oncologist?

A new diagnosis can feel overwhelming, but Hodgkin lymphoma is often highly treatable. Asking clear questions can help you feel more prepared.

Consider discussing your stage, treatment goals, expected benefits, possible side effects, fertility planning, clinical trials and survivorship care. Understanding each step empowers you to make informed decisions.

With modern therapies and close follow-up, many patients move through treatment and return to daily life. Building an open partnership with your oncology team supports you throughout the journey.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.